Home Investment Portfolio DLVR Therapeutics Innovation Type: Therapeutics Cancer Type: Liver Funding Stage: Proof of Concept Fund: Compass Rose Novel nanoparticle delivery technology Related news There are currently no news items related to this portfolio company. CONNECT WITH FACIT Learn more about how we are driving made-in-Ontario oncology innovations reach the market. Please note that only Ontario-based innovations related to oncology and cancer care are eligible for FACIT's investment and commercialization support. Name: Email: Message:
